CORNOVUS PHARMACEUTICALS
Cornovus Pharmaceuticals is a developer of a heart attack drug used to treat cardiac hypertrophy and heart failure. The technology increases myocardial cyclic guanosine-monophosphate which may play a role in cardia function and reperfusion enables heart attack victims to delay the onset of heart failure after a heart attack or injury. It was founded in 2011 and is headquartered in Farmington, Connecticut.
CORNOVUS PHARMACEUTICALS
Industry:
Health Care Health Diagnostics Medical Medical Device
Founded:
2011-01-01
Address:
Farmington, Connecticut, United States
Country:
United States
Website Url:
http://www.cornovus.com
Status:
Closed
Total Funding:
1.59 M USD
Current Employees Featured
Bruce Liang
Bruce Liang Founder @ Cornovus Pharmaceuticals Founder
Robert Mark Van Allen
Robert Mark Van Allen CEO @ Cornovus Pharmaceuticals CEO
Founder
Bruce Liang
Official Site Inspections
http://www.cornovus.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
Loading ...